A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, Keiji, Imai, Yumiko, Rao, Shuan, Gao, Hong, Guo, Feng, Guan, Bin, Huan, Yi, Yang, Peng +16 more·2005·Nature Medicine
DOI 10.1038/nm1267

Cited by (1,008)

Items 201–300 of 1,008

  1. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
    Francesca Salamanna, Melania Maglio, Maria Paola Landini, Milena Fini · 2020 · Frontiers in Medicine
  2. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
    Ioannis P. Trougakos, Kimon S. Stamatelopoulos, Evangelos Terpos, Ourania Tsitsilonis, Evmorfia Aivalioti, Dimitrios N. Paraskevis, Efstathios Kastritis, George N. Pavlakis, Meletios Athanasios Dimopoulos · 2021 · Journal of Biomedical Science
  3. Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-S-Protein Interactions
    Wenhui Li, Swee-Kee Wong, Fang Li, Jens H. Kuhn, I‐Chueh Huang, Hyeryun Choe, Michael Farzan · 2006 · Journal of Virology
  4. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
    Xiaoyan Liu, Zhe Li, Shuai Liu, Jing Sun, Zhanghua Chen, Min Jiang, Qingling Zhang, Yinghua Wei, Xin Wang, Yi-You Huang et al. · 2020 · Acta Pharmaceutica Sinica B
  5. COVID-19: A review of therapeutic strategies and vaccine candidates
    Vladislav Izda, Matlock Arizona Jeffries, Amr H. Sawalha · 2020 · Clinical Immunology
  6. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
    Onabajo, Olusegun O., Banday, A. Rouf, Stanifer, Megan L., Yan, Wusheng, Obajemu, Adeola, Santer, Deanna M., Florez-Vargas, Oscar, Piontkivska, Helen, Vargas, Joselin M., Ring, Timothy J. et al. · 2020 · Nature Genetics
  7. COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
    Amir A. Arastehfar, Agostinho Carvalho, M. Hong Nguyen, Mohammad Taghi Hedayati, Mihai Gheorghe Netea, David S. Perlin, Martin Hoenigl · 2020 · Journal of Fungi
  8. Mucosal immune responses to infection and vaccination in the respiratory tract
    Robert C. Mettelman, Emma Kaitlynn Allen, Paul Glyndwr Thomas · 2022 · Immunity
  9. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
    Razie Amraei, Nader Rahimi · 2020 · Cells
  10. Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits
    Shitao Rao, Alexandria Lau, Hon‐Cheong So · 2020 · Diabetes Care
  11. Physiology of Kidney Renin
    Hayo Castrop, Klaus Höcherl, Armin Kurtz, Frank Schweda, Vladimir Todorov, Charlotte Wagner · 2010 · Physiological Reviews
  12. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
    Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Argañaraz, Enrique Roberto Argañaraz · 2020 · Frontiers in Immunology
  13. Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor–Dependent Mechanism
    Matthew R. Deshotels, Huijing Xia, Srinivas Sriramula, Eric D. Lazartigues, Catalin M. Filipeanu · 2014 · Hypertension
  14. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
    Bhawna Tomar, Hans‐Joachim Anders, Jyaysi Desai, Shrikant R. Mulay · 2020 · Cells
  15. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
    Ryan M. Samuel, Homa Majd, Mikayla N Richter, Zaniar Ghazizadeh, Seyedeh Maryam Zekavat, Albertas Navickas, Jonathan T. Ramirez, Hosseinali Asgharian, Camille R. Simoneau, Luke R. Bonser et al. · 2020 · Cell stem cell
  16. Arterial hypertension
    Sofie Brouwers, Isabella Sudano, Yoshihiro Kokubo, Elisabeth M. Sulaica · 2021 · The Lancet
  17. The Novel Human Coronaviruses NL63 and HKU1
    Krzysztof Pyrć, Ben Berkhout, Lia van der Hoek · 2007 · Journal of Virology
  18. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review
    Alice Tamara, Dicky L. Tahapary · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  19. Heart failure and COVID-19
    Feras M. Bader, Yosef Manla, Bassam Atallah, Randall C. Starling · 2020 · Heart Failure Reviews
  20. SARS-CoV-2 Productively Infects Human Gut Enterocytes
    Mart Matthias Lamers, Joep Beumer, Jelte van der Vaart, Kèvin Knoops, Jens Puschhof, Tim I. Breugem, Raimond B. G. Ravelli, J. Paul van Schayck, Anna Z. Mykytyn, Hans Duimel et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  21. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
    P. Datta, Feng-Ming Liu, T. Fischer, J. Rappaport, X. Qin · 2020 · Theranostics
  22. Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
    Rami Sommerstein, Michael M. Kochen, Franz H. Messerli, Christoph Gräni · 2020 · Journal of the American Heart Association
  23. The Immunobiology of SARS
    Jun Chen, Kanta Subbarao · 2007 · Annual Review of Immunology
  24. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations
    Thomas Hanff, Michael Oscar Harhay, Tyler S. Brown, Jordana B. Cohen, Amir M. Mohareb · 2020 · Clinical Infectious Diseases
  25. Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
    Hongjing Gu, Zhengde Xie, Tieling Li, Shaogeng Zhang, Chengcai Lai, Ping Zhu, Keyu Wang, Lina Han, Yueqiang Duan, Zhongpeng Zhao et al. · 2016 · Scientific Reports
  26. The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
    Francesca Silvagno, Annamaria Vernone, Gianpiero Pescarmona · 2020 · Antioxidants
  27. ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
    Thomas Perlot, Josef Martin Penninger · 2013 · Microbes and Infection
  28. Essential role for collectrin in renal amino acid transport
    Ursula G. Danilczyk, Renu Sarao, Christine Remy, Chahira Benabbas, Gerti Stange, Andreas A. Richter, Sudha Arya, John Andrew Pospisilik, Dustin Singer, Simone M. R. Camargo et al. · 2006 · Nature
  29. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
    Awadhesh Kumar Singh, Ritesh Gupta, Anoop Misra · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  30. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
    Hoffmann, Markus, Hofmann-Winkler, Heike, Krüger, Nadine, Kempf, Amy, Nehlmeier, Inga, Graichen, Luise, Arora, Prerna, Sidarovich, Anzhalika, Moldenhauer, Anna-Sophie, Winkler, Martin S. et al. · 2021 · Cell Reports
  31. Perspective: Vitamin D deficiency and COVID‐19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis
    Jonathan Michael Rhodes, Sreedhar Subramanian, Eamon J. Laird, George Edward Griffin, Rose Anne Kenny · 2020 · Journal of Internal Medicine
  32. Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7)
    Carlos Maria Ferrario · 2005 · Hypertension
  33. Endothelial Damage in Acute Respiratory Distress Syndrome
    Alice Georgia Vassiliou, Αnastasia Kotanidou, Ioanna Dimopoulou, Stylianos E. Orfanos · 2020 · International Journal of Molecular Sciences
  34. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
    Publisher Chandrasekhara Rao Baru · 2014 · ADVANCED SCIENCES INDEX
  35. The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities
    Fraser R. Millar, Charlotte Summers, Mark Griffiths, Mark R. Toshner, Alastair G. Proudfoot · 2016 · Thorax
  36. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
    Jiqian Xu, Xiaobo Yang, Luyu Yang, Xiaojing Zou, Yaxin Wang, Yongran Wu, Ting Zhou, Yin Yuan, Hong Qi, Shouzhi Fu et al. · 2020 · Critical Care
  37. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
    Rakhee Kizhuvappat Ramakrishnan, Tarek Kashour, Qutayba A. Hamid, Rabih Halwani, Imad M. Tleyjeh · 2021 · Frontiers in Immunology
  38. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
    Juan Gómez, G. Albaiceta, M. García-Clemente, C. López-Larrea, L. Amado-Rodríguez, I. López-Alonso, Tamara Hermida, A. Enríquez, Pablo Herrero, S. Melón et al. · 2020 · Gene
  39. COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children
    Elena Ciaglia, Carmine Vecchione, Annibale Alessandro Puca · 2020 · Frontiers in Pediatrics
  40. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights
    Afshin A. Divani, Sasan Andalib, Mario Di Napoli, Simona Lattanzi, Muhammad Shazam Hussain, José Biller, Louise D. McCullough, Mahmoud Reza Azarpazhooh, Alina Seletska, Stephan A. Mayer et al. · 2020 · Journal of Stroke and Cerebrovascular Diseases
  41. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications
    Masae Iwasaki, Junichi Saito, Hailin Zhao, Atsuhiro Sakamoto, Kazuyoshi Hirota, Daqing Ma · 2020 · Inflammation
  42. Wuhan to World: The COVID-19 Pandemic
    Ashok Kumar, Rita Gill Singh, Jaskaran Kaur, Sweta Pandey, Vinita Sharma, Lovnish Thakur, Sangeeta Sati, Shailendra Mani, Shailendra Asthana, Tarun Kumar Sharma et al. · 2021 · Frontiers in Cellular and Infection Microbiology
  43. Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers are Not Associated with Severe COVID-19 Infection in a Multi-Site UK Acute Hospital Trust
    Daniel M. Bean, Željko Kraljević, Thomas Searle, Rebecca Bendayan, Kevin O’Gallagher, Andrew R. Pickles, Amos Folarin, Łukasz Roguski, Kawsar Noor, Anthony Shek et al. · 2020 · European Journal of Heart Failure
  44. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy In Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use
    Laxmaiah Manchikanti · 2020 · Pain Physician
  45. Cognitive impact of COVID-19: looking beyond the short term
    James Scott Miners, Patrick G. Kehoe, Seth Love · 2020 · Alzheimer s Research & Therapy
  46. Angiotensin‐Converting Enzyme 2: The First Decade
    Nicola E. Clarke, Anthony J. Turner · 2011 · International Journal of Hypertension
  47. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells
    Tapas Patra, Keith Meyer, Lizzie Geerling, Timothy Scott Isbell, Daniel Fredric Hoft, James D. Brien, Amelia K. Pinto, Ratna B. Ray, Ranjit Ray · 2020 · PLoS Pathogens
  48. Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
    Jordana B. Cohen, Thomas C. Hanff, Preethi William, Nancy K. Sweitzer, Nelson R. Rosado‐Santander, C. Medina, Juan Enrique Rodriguez Mori, Nicolas Federico Renna, Tara I. Chang, Vicente Corrales‐Medina et al. · 2021 · The Lancet Respiratory Medicine
  49. A new threat from an old enemy: Re‑emergence of coronavirus (Review)
    Anca Oana Docea, Aristidis Michael Tsatsakis, Dana Maria Albulescu, Oana Mariana Cristea, Ovidiu Mircea Zlatian, Marco Vinceti, Sterghios Athanasios Moschos, Dimitris Tsoukalas, Μαρίνα Γούμενου, Nikolaos Drakoulis et al. · 2020 · International Journal of Molecular Medicine
  50. Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
    Ye Qiu, Yuanbo Zhao, Qiong Wang, Jinyan Li, Zhijian Zhou, Ce-Heng Liao, Xing‐Yi Ge · 2020 · Microbes and Infection
  51. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea
    Di Ma, Chong‐Bo Chen, Vishal Jhanji, Ciyan Xu, Xiang‐Ling Yuan, Jiajian Liang, Yuqiang Huang, Ling‐Ping Cen, Tsz Kin Ng · 2020 · Eye
  52. The impact of novel coronavirus COVID‐19 on noncommunicable disease patients and health systems: a review
    Andrew Young Chang, Mark R. Cullen, Robert A. Harrington, Michèle Barry · 2020 · Journal of Internal Medicine
  53. Cellular host factors for SARS-CoV-2 infection
    Jim Baggen, Els Vanstreels, Sander Jansen, Dirk Daelemans · 2021 · Nature Microbiology
  54. SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes
    Cheng‐I Wu, Pieter Gerard Postema, Elena Arbelo, Elijah Raphael Behr, Connie R. Bezzina, Carlo Napolitano, Tomas Robyns, Vincent Probst, Eric Schulze‐Bahr, Carol Ann Remme et al. · 2020 · Heart Rhythm
  55. Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
    Dong P. Han, Adam Penn‐Nicholson, Michael W. Cho · 2006 · Virology
  56. Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019
    Sema Nickbakhsh, Antonia Ying Wai Ho, Diogo FP Marques, Jim McMenamin, Rory N. Gunson, Pablo R. Murcia · 2020 · The Journal of Infectious Diseases
  57. Human coronavirus NL63, a new respiratory virus
    Lia van der Hoek, Krzysztof Pyrć, Ben Berkhout · 2006 · FEMS Microbiology Reviews
  58. The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
    José Laerte Boechat, Inês Chora, António Morais, Luís Delgado · 2021 · Pulmonology
  59. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
    Han Zhu, June‐Wha Rhee, Paul P. Cheng, Sarah Waliany, Amy Chang, Ronald M. Witteles, Holden Terry Maecker, Mark M. Davis, Patricia Kim Phuong Nguyen, Sean M. Wu · 2020 · Current Cardiology Reports
  60. Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines
    Marcel A. Müller, Victor Stalin Raj, Doreen Muth, Benjamin Meyer, Stephan Kallies, Saskia L. Smits, Robert Wollny, Theo M. Bestebroer, Sabine Specht, Tasnim Suliman et al. · 2012 · mBio
  61. The Immune Response and Immunopathology of COVID-19
    Esmaeil Mortaz, Payam Tabarsi, Mohammad Varahram, Gert Folkerts, Ian Michael Adcock · 2020 · Frontiers in Immunology
  62. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications
    Nehla Banu, Sandeep Surendra Panikar, Lizbeth Riera Leal, Annie Riera Leal · 2020 · Life Sciences
  63. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
    Rafael B. Polidoro, Robert S. Hagan, Roberta Ribeiro De Santis Santiago, Nathan W. Schmidt · 2020 · Frontiers in Immunology
  64. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
    Konstantinos E. Farsalinos, Anastasia Barbouni, RAYMOND S. NIAURA · 2020 · Internal and Emergency Medicine
  65. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system
    Maria Grazia Lazzaroni, Silvia Piantoni, Stefania Masneri, Emirena Garrafa, Giuliana Martini, Anǵela Tincani, Laura Andréoli, Franco Franceschini · 2020 · Blood Reviews
  66. Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art
    Nastaran Taleghani, Fariborz Taghipour · 2020 · Biosensors and Bioelectronics
  67. Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis
    Yumiko Imai, Keiji Kuba, Takayo Ohto‐Nakanishi, Josef Martin Penninger · 2010 · Circulation Journal
  68. A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance
    Krishna Sriram, Paul A. Insel · 2020 · British Journal of Pharmacology
  69. Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases
    Keiji Kuba, Yumiko Imai, Josef Martin Penninger · 2013 · Circulation Journal
  70. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
    Supriya Ravichandran, Elizabeth M. Coyle, Laura Klenow, Juanjie Tang, Gabrielle Grubbs, Shufeng Liu, Tony T. Wang, Hana Golding, Surender Khurana · 2020 · Science Translational Medicine
  71. Development of ACE2 autoantibodies after SARS-CoV-2 infection
    John M. Arthur, James Craig Forrest, Karl W. Boehme, Joshua L. Kennedy, Shana M. Owens, Christian Herzog, Juan Liu, Terry Harville · 2021 · PLoS ONE
  72. The pulmonary pathology of COVID-19
    Bösmüller, Hans, Matter, Matthias, Fend, Falko, Tzankov, Alexandar · 2021 · Virchows Archiv
  73. Pathogenetic mechanisms of severe acute respiratory syndrome
    Yong Xia Guo, Christine Korteweg, Michael A. McNutt, Jiang Gu · 2007 · Virus Research
  74. Apelin is a positive regulator of ACE2 in failing hearts
    Teruki Sato, Takashi A. SUZUKI, Hiroyuki Watanabe, Ayumi Kadowaki, Akiyoshi Fukamizu, Peter P. Liu, Akinori Kimura, Hiroshi Ito, Josef Martin Penninger, Yumiko Imai et al. · 2013 · Journal of Clinical Investigation
  75. Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health
    Raony, Ícaro, de Figueiredo, Camila Saggioro, Pandolfo, Pablo, Giestal-de-Araujo, Elizabeth, Oliveira-Silva Bomfim, Priscilla, Savino, Wilson · 2020 · Frontiers in Immunology
  76. ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
    Li Xiao, Hiroshi Sakagami, Nobuhiko Miwa · 2020 · Viruses
  77. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis
    Sofia Viana, Sara Nunes, Flávio Reis · 2020 · Ageing Research Reviews
  78. COVID-19 and Obesity: Dangerous Liaisons
    Grazia Caci, Adriana Albini, Mario Malerba, Douglas McClain Noonan, Patrizia Pochetti, Riccardo Polosa · 2020 · Journal of Clinical Medicine
  79. Understanding Human Coronavirus HCoV-NL63~!2009-11-13~!2010-04-09~!2010-05-25~!
    Sahar Abdul‐Rasool, Burtram Clinton Fielding · 2010 · The Open Virology Journal
  80. The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease
    Majd AlGhatrif, Oscar H. Cingolani, Edward G. Lakatta · 2020 · JAMA Cardiology
  81. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
    Isabelle Bernard, Daniel Limonta, Lara K. Mahal, Tom C. Hobman · 2020 · Viruses
  82. Angiotensin-converting Enzyme 2 (ACE2), But Not ACE, Is Preferentially Localized to the Apical Surface of Polarized Kidney Cells
    Fiona J. Warner, Rebecca A. Lew, A. Ian Smith, D Lambert, Nigel M. Hooper, Anthony J. Turner · 2005 · Journal of Biological Chemistry
  83. Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A Perspective
    Thea Magrone, Manrico Magrone, Emilio Jirillo · 2020 · Endocrine Metabolic & Immune Disorders - Drug Targets
  84. Natural products for COVID ‐19 prevention and treatment regarding to previous coronavirus infections and novel studies
    Motahareh Boozari, Hossein Hosseinzadeh · 2020 · Phytotherapy Research
  85. Controlling Cytokine Storm Is Vital in COVID-19
    Lu Tang, Zhinan Yin, Yu Hu, Heng Mei · 2020 · Frontiers in Immunology
  86. Recombinant human ACE2: acing out angiotensin II in ARDS therapy
    Haibo Zhang, ANDREW J. BAKER · 2017 · Critical Care
  87. COVID-19, Myocarditis and Pericarditis
    Fairweather, DeLisa, Beetler, Danielle J., Di Florio, Damian N., Musigk, Nicolas, Heidecker, Bettina, Cooper, Leslie T. · 2023 · Circulation Research
  88. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor
    Anne M. Davidson, Jan A Wysocki, DANIEL C. BATLLE · 2020 · Hypertension
  89. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes
    Bonafè, Massimiliano, Prattichizzo, Francesco, Giuliani, Angelica, Storci, Gianluca, Sabbatinelli, Jacopo, Olivieri, Fabiola · 2020 · Cytokine & Growth Factor Reviews
  90. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection
    Cornelia Blume, Claire L. Jackson, Cosma Mirella Spalluto, Jelmer Legebeke, Liliya Nazlamova, Franco Conforti, Jeanne‐Marie Perotin, Martin Frank, John Butler, Max Crispin et al. · 2021 · Nature Genetics
  91. Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
    Eric D. Lazartigues, Mirza Muhammad Fahd Qadir, Franck Mauvais‐Jarvis · 2020 · Endocrinology
  92. Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?
    Fabio Perrotta, Maria Gabriella Matera, Mario Cazzola, Andrea Bianco · 2020 · Respiratory Medicine
  93. ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis
    Xue Zhang, Jiong Yu, Li‐ya Pan, Hai-yin Jiang · 2020 · Pharmacological Research
  94. COVID-19 as an Acute Inflammatory Disease
    Rose H. Manjili, Melika Zarei, Mehran Habibi, Masoud H. Manjili · 2020 · The Journal of Immunology
  95. Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection
    Barry Rockx, Tracey Baas, Gregory A. Zornetzer, Bart L. Haagmans, Timothy Patrick Sheahan, Matthew B. Frieman, Matthew D. Dyer, Thomas H. Teal, Sean C Proll, Judith M. A. van den Brand et al. · 2009 · Journal of Virology
  96. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective
    Marouane Boukhris, Ali Hillani, Francesco Moroni, Mohamed‐Salah Annabi, Faouzi Addad, Marcelo Harada Ribeiro, Samer Mansour, Xiaohui Zhao, Luiz F. Ybarra, Antonio Abbate et al. · 2020 · Canadian Journal of Cardiology
  97. Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology
    Simon J. Cleary, Simon C. Pitchford, Richard Thomas Amison, Robert Carrington, C. Lorena Robaina Cabrera, Mélia Magnen, Mark R. Looney, Elaine Gray, Clive Peter Page · 2020 · British Journal of Pharmacology
  98. Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19
    Shigeru Shibata, Hisatomi Arima, Kei Asayama, Satoshi Hoshide, Atsuhiro Ichihara, Toshihiko Ishimitsu, Kazuomi Kario, Takuya Kishi, Masaki Mogi, Akira Nishiyama et al. · 2020 · Hypertension Research
  99. SARS-CoV-2, ACE2 expression, and systemic organ invasion
    Usman Ashraf, Ahmed A. Abokor, Jonnelle M. Edwards, Emily W. Waigi, Rachel Royfman, Syed Abdul‐Moiz Hasan, Kathryn Smedlund, Ana Maria Trindade Grégio, Ritu Chakravarti, Lauren G. Koch · 2020 · Physiological Genomics
  100. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome
    Mariusz Z. Ratajczak, Kamila Bujko, Andrzej Krzysztof Ciechanowicz, Kasia Sielatycka, Monika Cymer, Wojciech M. Marlicz, Magda Kucia · 2020 · Stem Cell Reviews and Reports